Free Trial

Tiziana Life Sciences (TILS) News Today

Tiziana Life Sciences logo
Tiziana enters product development services agreement with Renaissance
Tiziana Life Sciences announces discovery of new immune biomarkers
Tiziana Life Sciences Expands MS Clinical Trial Network
Tiziana Life Sciences Plans Share Sale with Jefferies
Tiziana Life Appoints Ivor Elrifi As CEO
Tiziana Life Sciences Appoints Ivor Elrifi as CEO
Tiziana Life Sciences Ltd (0RP)
Tiziana Life Sciences CEO purchases shares
Tiziana Life Sciences
Advan Co Ltd (7463)
Tiziana Life Sciences: Multiple Sclerosis single study
2022 update: US listing and fresh data emerging
Get Tiziana Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for TILS and its competitors with MarketBeat's FREE daily newsletter.

TILS Media Mentions By Week

TILS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TILS
News Sentiment

0.63

0.60

Average
Medical
News Sentiment

TILS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TILS Articles
This Week

4

0

TILS Articles
Average Week

Get Tiziana Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for TILS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (LON:TILS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners